Terms: = Liver cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Diagnosis
27 results:
1. COP9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma.
Liu J; Han D; Xuan J; Xie J; Wang W; Zhou Q; Chen K
Aging (Albany NY); 2024 Mar; 16(6):5264-5287. PubMed ID: 38466642
[TBL] [Abstract] [Full Text] [Related]
2. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
[TBL] [Abstract] [Full Text] [Related]
3. Risk factors and actionable molecular signatures in COVID-19-associated lung adenocarcinoma and lung squamous cell carcinoma patients.
Ullah MA; Alam S; Moin AT; Ahamed T; Shohael AM
Comput Biol Med; 2023 May; 158():106855. PubMed ID: 37040675
[TBL] [Abstract] [Full Text] [Related]
4. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates liver cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
Wang J; Yu H; Dong W; Zhang C; Hu M; Ma W; Jiang X; Li H; Yang P; Xiang D
Gastroenterology; 2023 May; 164(6):990-1005. PubMed ID: 36764493
[TBL] [Abstract] [Full Text] [Related]
5. Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesis.
Kim BK; Kim DM; Park H; Kim SK; Hwang MA; Lee J; Kang MJ; Byun JE; Im JY; Kang M; Park KC; Yeom YI; Kim SY; Jung H; Kweon DH; Cheong JH; Won M
J Exp Clin Cancer Res; 2022 Jun; 41(1):212. PubMed ID: 35768842
[TBL] [Abstract] [Full Text] [Related]
6. [Clinicopathological festures and outcome of combined hepatocellular-cholangiocarcinoma].
Ye DL; Zong JW; Luo JX; Cui WZ; Wang W
Zhonghua Yi Xue Za Zhi; 2022 May; 102(18):1369-1373. PubMed ID: 35545581
[No Abstract] [Full Text] [Related]
7. Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity.
Fernández-Tussy P; Rodríguez-Agudo R; Fernández-Ramos D; Barbier-Torres L; Zubiete-Franco I; Davalillo SL; Herraez E; Goikoetxea-Usandizaga N; Lachiondo-Ortega S; Simón J; Lopitz-Otsoa F; Juan VG; McCain MV; Perugorria MJ; Mabe J; Navasa N; Rodrigues CMP; Fabregat I; Boix L; Sapena V; Anguita J; Lu SC; Mato JM; Banales JM; Villa E; Reeves HL; Bruix J; Reig M; Marin JJG; Delgado TC; Martínez-Chantar ML
Cell Death Dis; 2021 May; 12(6):555. PubMed ID: 34050139
[TBL] [Abstract] [Full Text] [Related]
8. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy.
Gowhari Shabgah A; Ezzatifar F; Aravindhan S; Olegovna Zekiy A; Ahmadi M; Gheibihayat SM; Gholizadeh Navashenaq J
IUBMB Life; 2021 Apr; 73(4):659-669. PubMed ID: 33625758
[TBL] [Abstract] [Full Text] [Related]
9. ASTN1 is associated with immune infiltrates in hepatocellular carcinoma, and inhibits the migratory and invasive capacity of liver cancer via the Wnt/β‑catenin signaling pathway.
Chen QF; Shi F; Huang T; Huang C; Shen L; Wu P; Li W
Oncol Rep; 2020 Oct; 44(4):1425-1440. PubMed ID: 32945491
[TBL] [Abstract] [Full Text] [Related]
10. Induction of Apoptosis by Coptisine in Hep3B Hepatocellular Carcinoma Cells through Activation of the ROS-Mediated JNK Signaling Pathway.
Kim SY; Hwangbo H; Lee H; Park C; Kim GY; Moon SK; Yun SJ; Kim WJ; Cheong J; Choi YH
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752099
[TBL] [Abstract] [Full Text] [Related]
11. PYCR1 interference inhibits cell growth and survival via c-jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer.
Zhuang J; Song Y; Ye Y; He S; Ma X; Zhang M; Ni J; Wang J; Xia W
J Transl Med; 2019 Oct; 17(1):343. PubMed ID: 31619254
[TBL] [Abstract] [Full Text] [Related]
12. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-jun/ap1 signaling by targeting ZNF418.
Wang L; Sun L; Wang Y; Yao B; Liu R; Chen T; Tu K; Liu Q; Liu Z
Int J Biol Sci; 2019; 15(7):1514-1522. PubMed ID: 31337980
[TBL] [Abstract] [Full Text] [Related]
13. A primary splenic angiosarcoma hepatic metastasis after splenectomy and its genomic alteration profile.
Cao L; Hong J; Wang Y; Yu J; Ma R; Li J; Wu J; Zheng S
Medicine (Baltimore); 2019 Jul; 98(28):e16245. PubMed ID: 31305404
[TBL] [Abstract] [Full Text] [Related]
14. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma.
Xue X; Zhao Y; Wang X; Qin L; Hu R
J Cell Biochem; 2019 Jan; 120(1):135-142. PubMed ID: 30238497
[TBL] [Abstract] [Full Text] [Related]
15. Screening effective differential expression genes for hepatic carcinoma with metastasis in the peripheral blood mononuclear cells by RNA-seq.
Shen Y; Bu L; Li R; Chen Z; Tian F; Lu N; Ge Q; Bai Y; Lu Z
Oncotarget; 2017 Apr; 8(17):27976-27989. PubMed ID: 28427195
[TBL] [Abstract] [Full Text] [Related]
16. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A
BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937
[TBL] [Abstract] [Full Text] [Related]
17. Laparoscopic ultrasound: a surgical "must" for second line intra-operative evaluation of pancreatic cancer resectability.
Piccolboni P; Settembre A; Angelini P; Esposito F; Palladino S; Corcione F
G Chir; 2015; 36(1):5-8. PubMed ID: 25827662
[TBL] [Abstract] [Full Text] [Related]
18. The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma.
Wang J; Tang X; Weng W; Qiao Y; Lin J; Liu W; Liu R; Ma L; Yu W; Yu Y; Pan Q; Sun F
Oncogene; 2015 Nov; 34(47):5781-95. PubMed ID: 25728681
[TBL] [Abstract] [Full Text] [Related]
19. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
[TBL] [Abstract] [Full Text] [Related]
20. Role of serum-ascites albumin gradient in differential diagnosis of ascites.
Younas M; Sattar A; Hashim R; Ijaz A; Dilawar M; Manzoor SM; Ali A; Khan FA
J Ayub Med Coll Abbottabad; 2012; 24(3-4):97-9. PubMed ID: 24669623
[TBL] [Abstract] [Full Text] [Related]
[Next]
